AMGN
Price
$438.80Alerts
Change
-$5.09 (-1.15%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
248.92B
82 days until earnings call
Intraday BUY SELL Signals
OGN
Price
$13.93Alerts
Change
+$0.01 (+0.07%)
Updated
Nov 19, 11:57 AM (EDT)
Capitalization
3.64B
91 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMGN vs OGN

AMGN vs OGN Comparison Chart in %
View a ticker or compare two or three
VS
AMGN vs. OGN commentary
Nov 19, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMGN is a Hold and OGN is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for AMGN with price predictions
Nov 18, 2026

AMGN's RSI Indicator recovers from overbought zone

The 10-day RSI Oscillator for AMGN moved out of overbought territory on November 05, 2026. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 46 instances where the indicator moved out of the overbought zone. In 25 of the 46 cases the stock moved lower in the days that followed. This puts the odds of a move down at 54%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AMGN as a result. In 33 of 75 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 44%.

The Moving Average Convergence Divergence Histogram (MACD) for AMGN turned negative on November 11, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 19 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 41%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AMGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 46%.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The 10-day moving average for AMGN crossed bullishly above the 50-day moving average on October 16, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 60%.

Following a +1.07% 3-day Advance, the price is estimated to grow further. Considering data from situations where AMGN advanced for three days, in 194 of 313 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.

AMGN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 149 of 272 cases where AMGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 55%.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is 4 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 59, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 14 (best 1 - 100 worst), indicating outstanding price growth. AMGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 15 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 36 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (21.297) is normal, around the industry mean (-1.421). P/E Ratio (28.386) is within average values for comparable stocks, (21.700). Projected Growth (PEG Ratio) (2.524) is also within normal values, averaging (5.738). Dividend Yield (0.022) settles around the average of (0.038) among similar stocks. P/S Ratio (5.371) is also within normal values, averaging (4.033).

A.I.Advisor
a Summary for OGN with price predictions
Nov 18, 2026

OGN's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for OGN turned positive on October 29, 2026. Looking at past instances where OGN's MACD turned positive, the stock continued to rise in 24 of 35 cases over the following month. The odds of a continued upward trend are 69%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on October 28, 2026. You may want to consider a long position or call options on OGN as a result. In 45 of 73 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.

Following a +0.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where OGN advanced for three days, in 180 of 284 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

The Aroon Indicator entered an Uptrend today. In 92 of 242 cases where OGN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 38%.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OGN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.

OGN broke above its upper Bollinger Band on November 03, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 40 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 41 (best 1 - 100 worst), indicating steady price growth. OGN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 53 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.621) is normal, around the industry mean (-1.421). P/E Ratio (17.557) is within average values for comparable stocks, (21.700). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.738). Dividend Yield (0.006) settles around the average of (0.038) among similar stocks. OGN's P/S Ratio (0.589) is slightly lower than the industry average of (4.033).

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 59, placing this stock worse than average.

FUNDAMENTALS RATINGS
AMGN: Fundamental Ratings
AMGN
OUTLOOK RATING
1..100
88
VALUATION
overvalued / fair valued / undervalued
1..100
79
Overvalued
PROFIT vs RISK RATING
1..100
4
SMR RATING
1..100
15
PRICE GROWTH RATING
1..100
14
P/E GROWTH RATING
1..100
36
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMGNOGN
RSI
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
63%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
58%
Bearish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 2 days ago
44%
Bullish Trend 2 days ago
62%
MACD
ODDS (%)
Bearish Trend 2 days ago
41%
Bullish Trend 2 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
50%
Bullish Trend 2 days ago
60%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
54%
Advances
ODDS (%)
Bullish Trend 11 days ago
62%
Bullish Trend 10 days ago
63%
Declines
ODDS (%)
Bearish Trend 2 days ago
46%
Bearish Trend 15 days ago
75%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
60%
Aroon
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
38%
COMPARISON
Comparison
Nov 19, 2026
Stock price -- (AMGN: $443.89 vs. OGN: $13.92)
Brand notoriety: AMGN: Notable vs. OGN: Not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AMGN: 92% vs. OGN: 160%
Market capitalization -- AMGN: $248.92B vs. OGN: $3.64B
AMGN [@Pharmaceuticals: Major] is valued at $248.92B. OGN’s [@Pharmaceuticals: Major] market capitalization is $3.64B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $4.8K to $1.21T. The average market capitalization across the [@Pharmaceuticals: Major] industry is $215.99B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMGN’s FA Score shows that 3 FA rating(s) are green while OGN’s FA Score has 1 green FA rating(s).

  • AMGN’s FA Score: 3 green, 2 red.
  • OGN’s FA Score: 1 green, 4 red.
According to our system of comparison, AMGN is a better buy in the long-term than OGN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMGN’s TA Score shows that 5 TA indicator(s) are bullish while OGN’s TA Score has 4 bullish TA indicator(s).

  • AMGN’s TA Score: 5 bullish, 4 bearish.
  • OGN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AMGN is a better buy in the short-term than OGN.

Price Growth

AMGN (@Pharmaceuticals: Major) experienced а -5.17% price change this week, while OGN (@Pharmaceuticals: Major) price change was +0.22% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -10.59%. For the same industry, the average monthly price growth was -9.02%, and the average quarterly price growth was -4.54%.

Reported Earning Dates

AMGN is expected to report earnings on Feb 09, 2027.

OGN is expected to report earnings on Feb 18, 2027.

Industries' Descriptions

@Pharmaceuticals: Major (-10.59% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

View a ticker or compare two or three
Interact to see
Advertisement

AMGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMGN has been loosely correlated with PFE. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGN jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMGN
1D Price
Change %
AMGN100%
-3.07%
PFE - AMGN
51%
Loosely correlated
-1.44%
GILD - AMGN
48%
Loosely correlated
-0.75%
ABBV - AMGN
48%
Loosely correlated
-2.33%
BIIB - AMGN
47%
Loosely correlated
+0.25%
MRK - AMGN
47%
Loosely correlated
-3.90%
More

OGN and

Correlation & Price change

A.I.dvisor tells us that OGN and AMGN have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OGN and AMGN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OGN
1D Price
Change %
OGN100%
+0.14%
AMGN - OGN
22%
Poorly correlated
-3.07%
BMY - OGN
22%
Poorly correlated
-2.92%
SNY - OGN
21%
Poorly correlated
-0.86%
BIIB - OGN
21%
Poorly correlated
+0.25%
GSK - OGN
21%
Poorly correlated
-1.34%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FGI4.610.26
+5.98%
FGI Industries Ltd
LCLN28.181.03
+3.79%
Lincoln International Inc
GEHC83.661.82
+2.22%
GE HealthCare Technologies
MRP25.070.01
+0.04%
Millrose Properties Inc
PRQR1.10-0.05
-4.35%
ProQR Therapeutics NV